Table 3.
The results of SUCRA.
| Treatment | 4 wk healing rates | 8 wk healing rates | Adverse event rate | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SUCRA | Pr. Best | MeanRank | Pr.Best | MeanRank | SUCRA | Pr. Best | MeanRank | ||
| Ome | 31.6 | 0.0 | 5.8 | 27.7 | 0.0 | 6.1 | 65.9 | 12.1 | 3.4 |
| Lan | 41.7 | 0.0 | 5.1 | 45.7 | 0.0 | 4.8 | 57.4 | 7.3 | 4.0 |
| Pan | 54.3 | 0.1 | 4.2 | 59.9 | 1.6 | 3.8 | 47.5 | 10.2 | 4.7 |
| Rab | 24.4 | 0.3 | 6.3 | 20.5 | 0.2 | 6.6 | 54.3 | 26.2 | 4.2 |
| Eso | 85.3 | 21.4 | 2.0 | 82.2 | 14.3 | 2.2 | 57.9 | 3.7 | 3.9 |
| Ila | 88.8 | 55.1 | 1.8 | 88.1 | 53.9 | 1.8 | 45.2 | 24.4 | 4.8 |
| Von | 73.9 | 23.2 | 2.8 | 75.9 | 30.0 | 2.7 | 41.0 | 7.4 | 5.1 |
| Pla | 0.0 | 0.0 | 8.0 | 0.0 | 0.0 | 8.0 | 30.7 | 8.8 | 5.8 |
Eso = esomeprazole, 40 mg/d; Ila = ilaprazole, 10 mg/d; Lan = lansoprazole, 30 mg/d; Ome = omeprazole, 20 mg/d; Pan = pantoprazole, 40 mg/d; PLA = placebo; Pr. Best = probability of being the best; Rab = rabeprazole, 20 mg/d; SUCRA = the surface under the cumulative ranking curve; Von = vonoprazan 20 mg/d.